1. Home
  2. JAGX vs TENX Comparison

JAGX vs TENX Comparison

Compare JAGX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$1.35

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$10.37

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
TENX
Founded
2013
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9M
56.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JAGX
TENX
Price
$1.35
$10.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$60.00
$17.00
AVG Volume (30 Days)
380.3K
157.3K
Earning Date
11-17-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,785,000.00
N/A
Revenue This Year
$22.41
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.45
N/A
52 Week Low
$1.00
$4.63
52 Week High
$33.25
$10.65

Technical Indicators

Market Signals
Indicator
JAGX
TENX
Relative Strength Index (RSI) 47.04 73.08
Support Level $1.05 $9.40
Resistance Level $1.36 $10.55
Average True Range (ATR) 0.14 0.60
MACD 0.04 0.09
Stochastic Oscillator 70.00 88.74

Price Performance

Historical Comparison
JAGX
TENX

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: